Resultados da pesquisa - Sanjeev Pathak
- A mostrar 1 - 8 resultados de 8
-
1
-
2
Safety Profile of Pimavanserin Therapy in Elderly Patients with Neurodegenerative Disease-Related Neuropsychiatric Symptoms: A Phase 3B Study Por Gus Alva, Wiesław Jerzy Cubała, Ana Berrio, Bruce Coate, Victor Abler, Sanjeev Pathak
Publicado em 2024Artigo -
3
Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects Por Gerard Sanacora, Mark A. Smith, Sanjeev Pathak, H-L Su, Peter H. Boeijinga, Dennis J. McCarthy, Michael C. Quirk
Publicado em 2013Artigo -
4
Mitigation of Olanzapine-Induced Weight Gain With Samidorphan, an Opioid Antagonist: A Randomized Double-Blind Phase 2 Study in Patients With Schizophrenia Por William Martin, Christoph U. Correll, Peter J. Weiden, Ying Jiang, Sanjeev Pathak, Lauren DiPetrillo, Bernard L. Silverman, Elliot Ehrich
Publicado em 2019Artigo -
5
Opioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studies Por Maurizio Fava, Michael E. Thase, Madhukar H. Trivedi, Elliot Ehrich, William Martin, Aslı Memişoğlu, Narinder Nangia, Arielle D. Stanford, Miao Yu, Sanjeev Pathak
Publicado em 2018Artigo -
6
Treatment for Adolescents With Depression Study (TADS) Por Graham J. Emslie, Christopher J. Kratochvil, Benedetto Vitiello, Susan G. Silva, Taryn L. Mayes, Steven McNulty, Elizabeth B. Weller, Bruce Waslick, Charles D. Casat, John T. Walkup, Sanjeev Pathak, Paul Rohde, Kelly Posner, John S. March
Publicado em 2006Artigo -
7
Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study Por Gerard Sanacora, Michael Johnson, Arif Khan, Sarah Atkinson, R. Riesenberg, Juan Schronen, Michael A. Burke, John Zajecka, L Barra, Hong-Lin Su, Joel A. Posener, Khanh Bui, Michael C. Quirk, Timothy M. Piser, Sanjay J. Mathew, Sanjeev Pathak
Publicado em 2016Artigo -
8
An Exploratory Analysis of the Impact of Family Functioning on Treatment for Depression in Adolescents Por Norah C. Feeny, Susan G. Silva, Mark A. Reinecke, Steven McNulty, Robert L. Findling, Paul Rohde, John F. Curry, Golda S. Ginsburg, Christopher J. Kratochvil, Sanjeev Pathak, Diane May, Betsy D. Kennard, Anne D. Simons, Karen C. Wells, Michele Robins, David Rosenberg, John S. March
Publicado em 2009Artigo
Ferramentas de pesquisa:
Assuntos relacionados
Alternative medicine
Internal medicine
Medicine
Pathology
Placebo
Psychology
Psychiatry
Anesthesia
Depression (economics)
Economics
Macroeconomics
Randomized controlled trial
Receptor
Antidepressant
Clinical endpoint
Schizophrenia (object-oriented programming)
Adjunctive treatment
Adverse effect
Antipsychotic
Hippocampus
Major depressive disorder
Mood
Opioid
(+)-Naloxone
Amygdala
Antagonist
Anthropology
Anxiety
Atypical antipsychotic
Bipolar I disorder